Normal human pituitaries were extracted in boiling water and acetic acid, and the a-amidated peptide products of pro-opiomelanocortin (POMC), a-melanocyte-stimulating hormone (aMSH), y-melanocytestimulating hormone (y1MSH), and amidated hinge peptide (HP-N), as well as their glycine-extended precursors, were characterized by sequence-specific radioimmunoassays, gel-chromatography, h.p.l.c. and amino acid sequencing. aMSH and y1MSH constituted 0.27-1.32% and 0.10-5.10%, respectively, of the POMC-derived products [calculated as the sum of adrenocorticotropic hormone (ACTH)-(1-39), ACTH-(1-14) and aMSH immunoreactivity]. aMSH and ACTH-(1-14) were only present in non-or monoacetylated forms. Only large forms of y1MSH and y2MSH were present in partly glycosylated states. The hinge peptides were amidated to an extent two to three orders of magnitude greater than aMSH and y1MSH. Most (99 %) of the HP-N was of low molecular mass and consisted mainly of HP-N-30. The remaining part was high-molecular-mass HP-N, probably HP-N-108, although the presence of HP-N-44 could not be completely excluded. These results show that all the possible amidated POMC-related peptides are present in normal human pituitary. It also shows that cleavage in vivo at all dibasic amino acids but one, takes place at the N-terminal POMC region; the exception is at the POMC-(49-50) N-terminal of the yMSH sequence. The pattern of peptides produced suggests that the generation of amidated peptides is mainly regulated at the endopeptidase level.
INTRODUCTION
Pro-opiomelanocortin (POMC) contains three main regions, i.e. the central, highly conserved adrenocorticotropic hormone [ACTH- ] sequence with ax-melanocyte-stimulating hormone (aMSH) as its N-terminus, the C-terminal ,-lipotropin, which is partly cleaved to ylipotropin and ,-endorphin, and the N-terminal yMSHcontaining sequence (Fig. 1 ). yMSH and its N-terminal extension are highly conserved in mammals showing more than 920% homology [1] [2] [3] [4] [5] [6] [7] , while the region between y1MSH and ACTH-(1-39) is more variable. This latter region has been named hinge peptide or joining peptide [8] .
Human POMC (Fig. 1 ) contains three putative amidation sites, i.e. X1-Gly-basic-basic-X2 in which X2 or basic-X2 is cleaved off by a trypsin-like endopeptidase (the remaining basic residues being removed by a carboxypeptidase B-like enzyme [9, 10] ) and glycine, subsequently cleaved by a Cu2+-, ascorbic acid-and 02- The amino acid sequence shown was deduced from the cDNA sequence of human pro-opiomelanocortin [6, 7] . The dibasic amino acids and the glycine residues, N-terminal to these putative cleavage sites, are boxed. The peptide products generated, assuming that only dibasic amino acids are cleaved, are indicated, particularly emphasizing the amidated peptides. y2MSH contains the C-terminal glycine-extended y1MSH peptide. Abbreviations: CLIP, corticotropin-like intermediate-lobe peptide; /JLPH, fl-lipotropin.
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dependent enzyme leaving X1 a-carboxyamidated [1 1,12] . The production of aMSH and its acetylation has been examined in several species including man [e.g. [13] [14] [15] , but there are only a few descriptions of amidated yMSH and HP-N in humans [8, [16] [17] [18] . The purpose of this study was to characterize all the a-amidated POMCderived peptides in normal human pituitary and to outline a processing pathway for these peptides.
MATERIALS AND METHODS

Materials
ACTH-(1-39), ACTH-(7-38), ACTH-(18-39), ACTH- (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) , N-acetyl-ACTH-(l-1 7), ACTH- (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) ,
,/MSH, sulphated and non-sulphated CCK-8 and gastrin-17 were obtained from Bachem (Bubendorf, Switzerland), CRB (Cambridge, U.K.) or Peninsula (Belmont, CA, U.S.A.). ACTH-(1-16) was kindly donated by CIBA-Geigy (Basel, Switzerland). An HP-N analogue, D-Tyr-Ala-Lys-Pro-Gly-Pro-Arg-Glu-NH2, and a glycine-extended analogue, D-Tyr-Ala-Lys-Pro-Gly-ProArg-Glu-Gly, were synthesized by CRB. Only the Nterminal amino acid was in the D-form; the remaining amino acids were L-forms. These sequences are identical to the 7 or 8 C-terminal amino acids in human hinge peptide, respectively. The D-form oftyrosine was included to prevent degradation of the peptides by aminopeptidases. The purity of peptides was controlled by h.p.l.c. as described below and by amino acid analysis on an LKB 4400 analyser (Biochrom, Cambridge, U.K.) after hydrolysis in 6 M-HCI at 110°C for 24 h. Carrierfree Na125I, 22NaCl and 1251-albumin were obtained from Amersham (Amersham, Bucks., U.K.) and lodogen (1,3,4,6-tetrachloro-3a,6a-diphenylglycouril) was from Pierce (Rockford, IL, U.S.A.). Bio-Gel PIO was purchased from Bio-Rad (Richmond, CA, U.S.A.), concanavalin A-Sepharose from Pharmacia (Uppsala, Sweden), Sep-Pak from Waters Associates (Milford, MA, U.S.A.) and C18-Nucleosil 300/5 from MacheryNagel (Diiren, West Germany). The C18-Lichrosorb used for tracer purification was from Merck (Darmstadt, West Germany).
Radioimmunoassays
Radioimmunoassays for ACTH-(1-39), ACTH-(1-14), aMSH, y1MSH and y2MSH have been described previously [19, 20] . Briefly, the ACTH-(1-39) radioimmunoassay was specific for the ACTH-(13-17) sequence and recognized ACTH-(1-17) and ACTH-(1-16), with an ED50 of 100 00, and ACTH-(l-16), with an ED50 of 320. This assay did not recognize ACTH- (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) or aMSH or any of the other peptides listed under 'Materials'. The ACTH-(1-14) radioimmunoassay recognized ACTH-(1-39), ACTH-(1-17), ACTH-{1-16) and aMSH with an ED50 of 1.6%, 1.5%, 2.9% and 2.1 00, respectively. The cMSH radioimmunoassay was completely specific for the amidated group of acMSH.
The two latter assays did not recognize any of the other peptides listed under 'Materials' and were not influenced by N-terminal modifications [19] . The y1MSH radioimmunoassay was specific for the C-terminal amidated group and recognized y2MSH with an ED50 of less than 0.050. The y2MSH-radioimmunoassay recognized y1MSH with an ED50 of less than 0.02%. None of the latter assays recognized the previously listed peptides [20] . Radioimmunoassay for HP-N was developed and performed as described for the other peptides [19] . The short HP-N analogue (see the Materials section) was coupled to bovine serum albumin by carbodi-imide, and antibodies were raised in rabbits [19] . The antiserum used in the assay was specific to the C-terminal amidated group of hinge peptides and recognized synthetic glycineextended hinge peptide with an ED50 of less than 0.020. No other POMC-derived peptides were recognized by the assay. 1251-hinge peptide was purified on C18-Lichrosorb at 50°C in 0.1 % trifluoroacetic acid and eluted in 40 min with an 18-23.5 o methanol gradient in 0.1 % trifluoroacetic acid. Labelled peptide was stabilized by adding 100,l of bovine serum albumin to 0.5 ml fractions collected and stored at 4 'C. Sensitivity of the assays varied from 1 fmol to 5 fmol.
Extraction of pituitaries
Pituitary tissue was obtained 6-16 h post-mortem from patients who died from non-endocrine diseases. The pituitaries were kept on ice and the anterior lobes were separated from the posterior lobes and the remnants of the intermediate lobe. These were subsequently frozen in liquid N2, cut into pieces, and boiled for 20 min in water (10 ml/g). The boiled pituitaries were homogenized in a Potter-Elvehjem homogenizer and centrifuged. The pellet obtained was extracted in an equal volume of 0.5 M-acetic acid for 30 min at room temperature and centrifuged. The water and acetic acid extracts were stored at -20 'C.
Gel filtration
Water and acetic acid extracts were pooled and subjected to gel filtration on a 1.1 cm x 96 cm column of Bio-Gel PIO. Peptides were eluted by 0.5 M-acetic acid at a flow rate of 10 ml/h at ambient temperature. . The columns were eluted with a flow rate of 1.0 ml/min and 0.5 ml of fractions were collected, evaporated and stored at -20°C. Each sample was reconstituted in 0.5 ml of 0.5 M-acetic acid before assay. The columns were calibrated using synthetic peptides. Concanavalin A-Sepharose Peptides were dissolved in 0.5 ml of 25 mM-Tris (pH 7.0) containing 0.5 M-NaCl, 1 .0 mM-CaC12 and 1.0 mM-MgCl2 and applied to an 0.5 ml column of concanavalin A-Sepharose. The column was washed in buffer at room temperature and eluted by a stepwise gradient of 0.1 M-and 0.5 M-ac-methyl D-mannoside.
Fractions (0.5 ml) were collected and assayed after addition of 100,l of 1 Qo bovine serum albumin.
Sequence analysis
Purified peptides were sequenced on a 470A protein sequencer (Applied Biosystems, CA, U.S.A.) and the phenylthiohydantoin (PTH) derivatives were identified by h.p.l.c. on a Hewlett Packard 1090 liquid chromatograph using a PTH-C18 column (2.1 mm x 220 mm) and a sodium acetate buffer/acetonitrile gradient elution system (both from Applied Biosystems).
Calculations
Correction for cross-reactivity of ACTH-(1-39), ACTH-(1-17), ACTH-(1-16) and aMSH in the ACTH-(1-14) radioimmunoassay, was made to all values in the Tables and Figures. The total amount of POMC and processed POMC was calculated as the sum of ACTH-(1-39), ACTH-(1-14) and aMSH immunoreactivity, which are derived from the same region in POMC and includes all the known forms of peptides in this region.
RESULTS
Pituitary extracts
Pituitaries were initially divided into anterior and neurointermediate lobes, the latter including the remnants of the intermediate lobe. However, no difference in the pattern of the extracted peptides could be detected. The peptide content was therefore calculated for whole pituitaries ( Table 1 ). The peptide content varied considerably, especially the ACTH-(1-39) content. The content of the individual peptides relative to total POMC also varied. Table 1 indicates the amount of amidated peptides relative to the sum of amidated and glycineextended peptides, i.e. total amount of processed peptides with the exception of HP-N because a radioimmunoassay for glycine-extended hinge peptide is not available. The HP-N content was 2-3-fold or more greater than the aMSH and y1MSH content.
Gel chromatography
Pooled water and acetic acid extracts were applied to Bio-Gel PlO columns (Fig. 2) . The recovery from the column of HP-N and ACTH was 220 and 31 %, respectively, in the chromatogram shown in Fig. 2 . The ratio HP-N/ACTH eluted from the column was 0.99 compared with 1.47 for the applied extract. More than 9500 of the ACTH-(1-39) immunoreactivity eluted at the same elution position as synthetic ACTH- (1-39) ; the remaining immunoreactivity eluted as high-molecularmass ACTH. A small shoulder was observed on the descending part of the ACTH-(1-39) peak which corresponds to the elution position of ACTH-(1-16) and ACTH-(1-17). ACTH-(1-14) and aMSH immunoreactivity eluted at greater Kav values than the synthetic peptides. Two main peaks were observed at Kav 1.1-1.2 and 1.4-1.5, respectively. This pattern was identical for all extracts investigated.
The HP-N eluted in three distinct peaks. All the pituitaries showed a similar pattern as was also found when anterior and neurointermediate lobes were chromatographed separately. The relative distribution of the indicated peaks was I (30 %), II (55 %) and IV (15 %).
The elution pattern of y1MSH immunoreactive peptides was heterogeneous, but two main peaks could be distinguished: the first in, or just after, the void volume of the column and the second at Kav. 0.35-0.45. No immunoreactivity was observed at the elution position of synthetic low-molecular-mass y1MSH or y2MSH. Fractions collected at the elution position of these peptides were pooled and concentrated. However, no y1MSH or y2MSH immunoreactivity could be detected in these pools. H.p.l.c. and sequence analysis
The ACTH-(1-14) and aMSH immunoreactivity in Fig. 2 were pooled as indicated, purified on Sep-Pak [19] , and subjected to h.p.l.c. in buffer system I. aMSH immunoreactivity eluted in two main peaks corresponding to the elution position of synthetic aMSH -and desacetyl-aMSH [ACTH-(1-13)-NH2] (Fig. 3) . These Ammonium acetate was used as the counter ion in these chromatograms (buffer system II). ACTH-(1-39) immunoreactivity eluted at a position corresponding to ACTH-(1-39) and ACTH-(7-38) which has been identified by Li et al. [21] (Fig. 4, upper panel) . Small peaks corresponding to the elution position of ACTH-(1-16) and ACTH-(1-17) were detected (Fig. 4 , middle and lower panel). The HP-N from pool II (Fig. 2) eluted in a single peak (Fig. 4, upper panel) . By contrast, the HP-N in pool IV eluted in two distinct peaks (lower panel). In the latter, a small amount of immunoreactivity eluted at the same position as the material in pool II.
The pools indicated in Fig. 4 were further purified by h.p.l.c. in buffer system III. More than 95 0 of the HP-N in pool Ila eluted as a single peak (Fig. 5) . Pool IVb eluted essentially as one peak, while pool IVa contained an additional peak eluting at the same position as the main peak in Ila. This was not a contaminant from pool II, as the peptides chromatographed in IVa were completely separated from the peptides in Ila by h.p.l.c. chromatography in buffer system II (Fig. 4) . The two main peaks in IVa and lVb were eluted in the reverse order of the elution pattern in Fig. 4 . The peaks indicated in Fig. 5 were pooled and partly sequenced. The sequence obtained from pool Ila is shown in Fig. 6 (Fig. 2) showed a sequence identical to the initial eight amino acids in HP-N-30.
The elution of the same peptides by PlO chromato- The pools indicated in Fig. 4 were chromatographed on C18-Nucleosil in buffer system III (see the Methods section). Note the difference in the scales. Buffer B was 90 % methanol in 10 mM-heptafluorobutyric acid. Fractions were pooled as indicated and the HP-N were sequenced (Fig. 6 ).
graphy at different elution positions and the appearance of the peak eluting at 28.5 min in Fig. 5 Fig. 2 was chromatographed on concanavalin A-Sepharose. The fraction of ACTH and y1MSH immunoreactivity absorbed was 65 % and 88 % respectively (results not shown). Too low an amount of high-molecular-mass HP-N was present for determination of the degree of glycosylation. DISCUSSION The results show that normal human pituitary contains all the amidated POMC products that can be extracted from the POMC sequence (Fig. 1) . The content of acMSH and y1MSH and their glycine-extended precursors were low and variable, while the amount of HP-N was up to 2-3 or more orders of magnitude greater than aMSH and y1MSH.
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Previous studies have established the initial cleavage of POMC to ACTH, ,B-lipotropin and 16 kDa N-terminal fragments as well as the further processing of ACTH to aMSH as shown in Fig. 7 [1] . The processing pathway of the N-terminal fragment HP-N-108 is only tentative because dynamic studies on this part of the precursor are lacking. However, several findings support this pattern of processing. First, N-POMC-(1-76) is the only y3MSH immunoreactivity (Fig. 1 ) detected in man [22, 24] . This would suggest that no cleavage takes place at POMC-(49-50), a conclusion supported by detection of only high-molecular-mass forms of y1MSH (Fig. 2) . If cleavage at POMC-(49-50) does occur, low-molecularmass y1MSH would have been expected to be found. Furt-hermore, only two forms of HP-N could be detected, i.e. HP-N-108 and HP-N-30, and modified analogues. These findings suggest that the principle cleavage products of the N-terminal POMC are N-POMC-(1-76) and HP-N-30 (Fig. 7) .
This model implicates that the most likely source of high-molecular-mass y1MSH is N-POMC-(1-76). Alternatively, this y1MSH immunoreactivity could be derived directly from HP-N-108. The lack of detection of HP-N-44, which would be produced concomitantly, cannot exclude this possibility, as HP-N-44 could have been cleaved very quickly to HP-N-30 (Fig. 7) . In fact, both [27] , but a few aMSH-producing cells can be detected in the anterior lobe by immunohistochemistry [26] . However, these aMSH-cells were too scarce to produce detectable amounts of low-molecular-mass yMSH. In accordance with this, no HP-N-58 or y3MSH [22] [23] [24] were detected (Fig. 1) .
The anterior lobe is rich in a-amidating activity [12] , but it has been shown that the efficiency of cleavage of the C-terminal glycine is dependent on the amino acid being amidated [11] . Glutamate, as present in hinge peptide, is a poor substrate, but actually HP-N is by far the most abundant amidated peptide in the human pituitary. This suggests that the content of a-amidated peptides is mainly determined by the extent of endopeptidic cleavage and only to a lesser extent by the aamidation process itself. This is supported by the processing of cholecystokinin in human pituitary [28] .
It was somewhat surprising to find that the main part of the HP-N was conjugated by disulphide linkages (peaks I and II, Fig. 2 ). The conjugation was not a consequence of post-mortem modification, because the same degree of conjugation was detected in pituitary tumours frozen immediately after surgery (Fenger & Johnsen, unpublished results). Although it was not possible to define the molecules conjugated to HP-N-30, the consistent elution of peak II by gel chromatography and h.p.l.c., strongly suggests that only one molecular species conjugates to HP-N-30. The sequence data of purified peak II, suggest that HP-N-30 itself or its Cterminal glycine-extended precursor are the most likely candidates. Conjugation to an N-terminal-blocked cysteine-containing peptide cannot be excluded, since such a peptide would have escaped the sequence analysis. The HP-N-30 in peak I could be conjugated to any 16 kDa N-POMC fragment, but any cysteine-containing peptide or protein would be a candidate. Further experiments are needed to elucidate the exact conjugation of HP-N-30 and its significance.
All the HP-N/POMC ratios were greater than 1.0 (Table 1) . This could be due to an underestimation of the ACTH-(1-39) content in the extracts. As only one POMC gene has been detected [6, 7, 29] , and no alternative splicing of the mRNA has been demonstrated, the most probable reason for this low ACTH-(1-39) content is autolysis in the post-mortem tissue [30] . This is supported by HP-N/POMC ratios of not greater than 0.6 in pituitaries obtained on surgery and immediately frozen (Fenger & Johnsen, unpublished results). However, except for the calculation of the relative values of a-amidated peptides being too high, the underestimation of the ACTH-(1-39) content does not affect the proposed pathway of processing discussed above.
A physiological function for the pituitary-derived peptides has only been established for ACTH-(1-39) [31, 32] . It has been suggested that yMSH-related peptides are involved in steroidogenesis in the adrenal gland [33] [34] [35] [36] [37] [38] [39] at least in synergism with ACTH- (1-39) . However, the physiological effects of pituitary-derived amidated peptides in humans essentially remains to be determined.
